SESSION II: TRANSLATIONAL PATHWAY FOR TRANSCATHETER AORTIC VALVE
SESSION III: TRANSLATIONAL PATHWAY FOR TRANSCATHETER MITRAL/TRICUSPID VALVE DEVICES
2 of 5

The TAVR Development from Concept to First in Man

Alain Cribier, MD

Professor of Medicine and Director of Cardiology at the

University of Rouen, Charles Nicolle Hospital, France

Learning Objectives

  • Recognize the challenges to design iteration
  • Understand the tailored trial design
  • Learn the regulatory pathway for approval for device iteration
  • Learn the regulatory pathway for approval for indication expansion
  • Learn the use of real world data